XML 39 R56.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK-BASED COMPENSATION (Details 4) (USD $)
Share data in Thousands, except Per Share data, unless otherwise specified
12 Months Ended 1 Months Ended 1 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2013
Employee Stock Option [Member]
Dec. 31, 2013
Restricted Stock [Member]
Dec. 31, 2013
Employee Stock Option and Restricted Stock [Member]
Dec. 31, 2012
Employee Stock Option and Restricted Stock [Member]
Jul. 31, 2013
2008 Plan [Member]
Dec. 31, 2013
2008 Plan [Member]
Nov. 30, 2013
2008 Plan [Member]
Restricted Stock [Member]
Jul. 31, 2013
BioSante Plans [Member]
Share-based Compensation Arrangement by Share-based Payment Award                    
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant               136    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number               325    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 21 0         21      
Stock-based compensation expense         $ 36,000 $ 0        
Share-based Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value               $ 3.40    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms                 2 years 10 months 2 days  
Unrecognized compensation cost (in dollars)     63,000              
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition 3 years 6 months 11 days     2 years 10 months 2 days            
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period     10 years              
Share Based Compensation Arrangement By Share Based Payment Award Options Assumed In Business Combination 99                 99
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period                 50  
Unrecognized compensation cost (in dollars)       $ 500,000